Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK39775 monotherapy in advanced solid tumors (Phase I/II)
CTR20240645Phase 2Active
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HSK39775 in Non-hematologic malignancy, sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Mar 2024; status: active.
02
Drugs
HSK39775
03
Conditions
Non-hematologic malignancy
Beyond the preview
Go deeper on CTR20240645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240645.